The authors have no funding, financial relationships or conflict of interest to disclose.
This material has never been published and is not currently under evaluation in any other peer-reviewed publication.
KI and TK were involved in all stages of the study. NM was involved in measurement of MIC. All authors gave final approval for the publication of this manuscript. All authors read and approved the final manuscript.
The aim of the present study was to evaluate the bactericidal activity of four new fluoroquinolones against current isolates of Pseudomonas aeruginosa from the patients with chronic suppurative otitis media (CSOM).
We examined bactericidal activity of four types of fluoroquinolones, garenoxacin (GRNX), levofloxacin (LVFX), ciprofloxacin (CPFX) and sitafloxacin (STFX) against current isolates of P. aeruginosa (50 strains).
STFX exhibited the most potent activity of both MIC50 and MIC90, followed by CPFX, LVFX, and GRNX. The number of GRNX-resistant strains was significantly greater than those of LVFX, CPFX, and STFX (P < 0.05).
STFX showed the most potent activity against P. aeruginosa for recent pathogens recovered from CSOM as compared with the others, suggesting that the clinical application of topical STFX would be useful to prevent the emergence of resistant mutants of P. aeruginosa.
WHO and UNICEF. Management of children illness. Gneva: WHO/CDR/95.14A-LHO; 2004.
Meyerhoff WL. Pathology of chronic suppurative otitis media. Ann Otol Rhinol Laryngol. 1988;97 suppl 131:21–4.
Institute CaLS. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. Seventh edition. M7-A7 Wayne: 2006.
Institute CaLS. Performance standards for antimicrobial susceptibility testing; 17th informational supplement. M100-S17 Wayne PA: Clinical and Laboratory Standards Institute; 2007.
Institute CLS. Performance standards for antimicrobial susceptibility testing; 22nd informational supplement. Wayne, PA: Document M100-S22 Clinical Laboratory Standards Institute; 2012.
Watanabe A, Yanagihara K, Matsumoto T, Kohno S, Aoki N, Oguri T, et al. Nationwide surveillance of bacterial respiratory pathogens conducted by the Surveillance Committee of Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Clinical Microbiology in 2009: general view of the pathogens’ antibacterial susceptibility. J Infect Chemother. 2012;18:609–20. CrossRefPubMed
- Comparative bactericidal activity of four fluoroquinolones against Pseudomonas aeruginosa isolated from chronic suppurative otitis media
- BioMed Central
Neu im Fachgebiet HNO
Mail Icon II